Rotavirus vaccines in Israel: Uptake and impact
We present an overview of the impact of universal rotavirus immunization with the pentavalent vaccine, RotaTeq, which was introduced in Israel in 2010. The vaccine is given free of charge at age 2, 4 and 6 months, with an 80% coverage that was shortly achieved during the universal immunization perio...
Main Authors: | Khitam Muhsen, Daniel Cohen |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2017-07-01
|
Series: | Human Vaccines & Immunotherapeutics |
Subjects: | |
Online Access: | http://dx.doi.org/10.1080/21645515.2017.1297908 |
Similar Items
-
Experiences with rotavirus vaccines: can we improve rotavirus vaccine impact in developing countries?
by: A.D. Steele, et al.
Published: (2019-06-01) -
Rotavirus vaccination
by: V. K. Tatochenko
Published: (2016-12-01) -
A decade of experience with rotavirus vaccination in the United States – vaccine uptake, effectiveness, and impact
by: Talia Pindyck, et al.
Published: (2018-07-01) -
THE BURDEN OF ROTAVIRUS GASTROENTERITIS, AS THE RATIONALE FOR ROUTINE VACCINATION
by: S M. KHARIT, et al.
Published: (2017-05-01) -
Projecting the effectiveness of RotaTeq® against rotavirus-related hospitalisations in Brazil
by: Antoine Chaouki El Khoury, et al.
Published: (2011-08-01)